DEBRA KOOPMAN: Open Payments
NPI 1326325945 · MARLBOROUGH, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$267 in 12 payments from 7 companies in 2025. Trend: 2023 $396 · 2024 $395 · 2025 $267
Food & beverage: $267
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $87 |
| Axsome Therapeutics, Inc. | 2 | $51 |
| ABBVIE INC. | 2 | $47 |
| E.R. Squibb & Sons, L.L.C. | 1 | $33 |
| Lundbeck LLC | 1 | $20 |
| Tris Pharma Inc | 1 | $14 |
| Alkermes, Inc. | 1 | $14 |
Products named: CAPLYTA, Auvelity, VRAYLAR, COBENFY, REXULTI, Dyanavel XR, ARISTADA.
Industry payments across MA — which companies pay providers there.
